Apellis Pharmaceuticals to Hold First Quarter 2021 Earnings Conference Call on April 28, 2021

Rhea-AI Summary

Apellis Pharmaceuticals (APLS) will hold a conference call on April 28, 2021, at 4:30 p.m. ET to discuss its Q1 2021 financial results. Investors can join the call by dialing (866) 774-0323 for domestic calls or (602) 563-8683 for international calls, entering conference ID # 7883183. The event can also be accessed via webcast from the company’s website. Apellis is focused on developing targeted C3 therapies for various diseases driven by excessive activation of the complement cascade.

WALTHAM, Mass., April 21, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company will host a conference call and webcast to discuss its first quarter 2021 financial results on Wednesday, April 28, 2021 at 4:30 p.m. ET.

The event will be available live by dialing (866) 774-0323 (domestic) or (602) 563-8683 (international) and entering the conference ID # 7883183 or via webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website at https://investors.apellis.com/events-and-presentations. A replay of the webcast will be available for 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit www.apellis.com.

Investor Contact:
Argot Partners
apellis@argotpartners.com
+1 212.600.1902

FAQ

When is Apellis Pharmaceuticals' Q1 2021 earnings call?

The Q1 2021 earnings call for Apellis Pharmaceuticals will take place on April 28, 2021, at 4:30 p.m. ET.

How can I access Apellis Pharmaceuticals' earnings call?

You can access the earnings call by dialing (866) 774-0323 for domestic calls or (602) 563-8683 for international calls, using conference ID # 7883183, or via webcast on the company's website.

What is Apellis Pharmaceuticals focused on?

Apellis Pharmaceuticals is focused on developing targeted C3 therapies for diseases affected by the complement cascade.